StockData
Collegium Pharmaceutical, Inc logo

Collegium Pharmaceutical, Inc (COLL) income statement

COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$25.55+0.12 (+0.47%)

Close on Nov 17, 2026Market cap $831.80MP/E 20.6Yield –

Collegium Pharmaceutical, Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
60.0%
Operating margin
19.5%
Net margin
5.9%
Return on equity, FY2025
23.7%

Financial strength

Current ratio
1.03
Debt to equity
–
Debt to assets
–
Cash to current liabilities
21.9%

Valuation

P/E ratio
20.6
Price to sales
1.03
Price to book
2.67
Dividend yield
–

See a number that looks wrong?